IP Strategy + Consulting

Technology Licensing

Case Studies

Sale of Major Business Application Software Company

Kegler Brown represented the controlling shareholder of TDCI, Inc. in its sale of TDCI to Infor (US), Inc. TDCI, headquartered in Columbus, Ohio, provides leading software product configuration management solutions to manufacturers and distributors of customizable products and services. Infor is a leading provider of business application software that serves more than 70,000 customers in 194 countries. Financial terms of the May 2013 transaction were not disclosed.

Lead U.S. Counsel for U.K.-Based Green Tech Company in Strategic U.S. Acquisition

Our firm's emerging business lawyers served as lead U.S. counsel for a prominent U.K.-based green technology company in a major acquisition in the U.S. The transaction involved complex IP licensing that allowed for the engineering and design for conversion of an ethanol plant into a producer of bio-butanol and other high-value chemicals from corn-based feedstock.

IP Counsel for Columbus-Based Green Tech Start-Up

Kegler Brown's intellectual property lawyers serve as strategic IP counsel for an Ohio-based growth company specializing in the production and processing of high-value chemicals derived from lake algae and other waste products.

Historic Agreement between U.S. and Cuba Pharmaceutical Companies

Since 2015, our firm has served as counsel to Mercurio Biotech, a start-up U.S. biotech company, throughout a lengthy negotiation process with Cuban state owned biotechnology companies.

This involved advice on complex regulatory, legal and political matters, as well as numerous meetings in Washington, D.C., with U.S. regulators and officials, and many meetings in Havana with Cuban officials to negotiate various agreements. In 2018, these negotiations resulted in agreements between the Cuban company Heber Biotec S.A. and Mercurio Biotec to bring the Cuban diabetic foot ulcer medication Heberprot-P to the United States for clinical trials and, if approved by the FDA, commercialization of Heberprot-P in the U.S. The agreements are historic within the context of U.S.-Cuba political and business relations and Kegler Brown is only the second U.S. law firm to successfully complete any such agreements with Cuba. Kegler Brown continues to provide counsel as these agreements progress into new phases.